ImportRefusal LogoImportRefusal

Groupe Parima Inc.

⚠️ High Risk

FEI: 3003773810 • Saint-Laurent, Quebec • CANADA

FEI

FEI Number

3003773810

📍

Location

Saint-Laurent, Quebec

🇨🇦

Country

CANADA
🏢

Address

4450 Cousens St, , Saint-Laurent, Quebec, Canada

High Risk

FDA Import Risk Assessment

51.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

33
Total Refusals
4
Unique Violations
9/3/2019
Latest Refusal
1/4/2002
Earliest Refusal

Score Breakdown

Violation Severity
80.5×40%
Refusal Volume
56.7×30%
Recency
0.0×20%
Frequency
18.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7525×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1187×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

727×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

162×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

Refusal History

DateProductViolationsDivision
9/3/2019
61WRL18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
72NEW VET DR
Division of Northern Border Imports (DNBI)
9/3/2019
61WRL18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
72NEW VET DR
Division of Northern Border Imports (DNBI)
9/3/2019
61WRL18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
72NEW VET DR
Division of Northern Border Imports (DNBI)
8/15/2017
61WQL47KETOCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
72NEW VET DR
Division of Northern Border Imports (DNBI)
8/15/2017
61WQL47KETOCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
72NEW VET DR
Division of Northern Border Imports (DNBI)
6/19/2017
61WRL18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
72NEW VET DR
Division of Northern Border Imports (DNBI)
6/19/2017
61WRL18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
72NEW VET DR
Division of Northern Border Imports (DNBI)
2/23/2017
61WRL18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Detroit District Office (DET-DO)
2/23/2017
61WRL18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Detroit District Office (DET-DO)
4/5/2016
62FBK53MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
12/4/2014
61HDK45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III)
75UNAPPROVED
Detroit District Office (DET-DO)
7/31/2012
61HCL45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III)
75UNAPPROVED
New York District Office (NYK-DO)
7/31/2012
61HCL45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III)
75UNAPPROVED
New York District Office (NYK-DO)
7/31/2012
61HCL45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III)
75UNAPPROVED
New York District Office (NYK-DO)
7/31/2012
64XCL06SALICYLIC ACID (KERATOLYTIC)
75UNAPPROVED
New York District Office (NYK-DO)
7/31/2012
61HCL45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III)
75UNAPPROVED
New York District Office (NYK-DO)
7/31/2012
61HCL45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III)
75UNAPPROVED
New York District Office (NYK-DO)
7/31/2012
61HCL45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III)
75UNAPPROVED
New York District Office (NYK-DO)
7/31/2012
61HCL45SODIUM SULFACETAMIDE (ANTI-BACTERIAL, PART III)
75UNAPPROVED
New York District Office (NYK-DO)
8/2/2011
61GDJ45SULFACETAMIDE SODIUM (ANTI-BACTERIAL) (NOT ANTIBIOTIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
7/27/2011
64DCJ99EMOLLIENT, LUBRICANT, N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
7/27/2011
64DCJ99EMOLLIENT, LUBRICANT, N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
7/15/2011
64DCJ99EMOLLIENT, LUBRICANT, N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
7/15/2011
64XCJ03BENZOYL PEROXIDE (KERATOLYTIC)
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
New York District Office (NYK-DO)
4/28/2011
61GDL45SULFACETAMIDE SODIUM (ANTI-BACTERIAL) (NOT ANTIBIOTIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
3/31/2011
62SDL99ANTI-SEBORRHEIC N.E.C.
75UNAPPROVED
Detroit District Office (DET-DO)
3/31/2011
62SBL99ANTI-SEBORRHEIC N.E.C.
75UNAPPROVED
Detroit District Office (DET-DO)
3/31/2011
64EDJ13TRYPSIN CRYSTALLIZED (ENZYME)
75UNAPPROVED
Division of Northern Border Imports (DNBI)
12/7/2010
60QDJ40LIDOCAINE HCL (ANESTHETIC)
75UNAPPROVED
Detroit District Office (DET-DO)
9/23/2002
64DCJ99EMOLLIENT, LUBRICANT, N.E.C.
118NOT LISTED
New York District Office (NYK-DO)
1/4/2002
66V99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
1/4/2002
60QDY40LIDOCAINE HCL (ANESTHETIC)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
1/4/2002
66V99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Groupe Parima Inc.'s FDA import refusal history?

Groupe Parima Inc. (FEI: 3003773810) has 33 FDA import refusal record(s) in our database, spanning from 1/4/2002 to 9/3/2019.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Groupe Parima Inc.'s FEI number is 3003773810.

What types of violations has Groupe Parima Inc. received?

Groupe Parima Inc. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Groupe Parima Inc. come from?

All FDA import refusal data for Groupe Parima Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.